Heavy Bond Pressure Continues to Hurt Stocks
The dismal market action continues.
The market may not be selling off solely because of oil and Iran. Investors may be starting to price in another troubling risk.
Ocular Therapeutix is selling off sharply, taking our small-cap portfolio down with it.
Let me explain how I’m playing SPCX and how it fits into my trading style.
The news likely helped push the major space stocks higher.
Here are our thoughts on the market, our shopping list, Paccar, and a potential new name.
We’ve already got a market-relevant impact on tariffs, but what are the other main points of contention as the “G2” gather?
We’re adding this membership-driven company to our shopping list.
Plus, Ciena gets an upgrade, market index changes, and Well Fargo on diesel prices.
Finally, investors started to show some concern on Thursday, but by Friday, they were back and getting excited about the semis, which concerns me.